According to the SEC’s latest filings, institutions owning shares of CRISPR Therapeutics AG (:CRSP) have increased their transactions by 0.58%. Institutions now own 46.80% of the company.
Investors will most likely make plenty of mistakes when dealing with the equity market. Learning from these mistakes is what will propel the individual forward. Those who don’t learn from their mistakes are destined to repeat, and failure might be right around the corner. Every investor strives to spot that uncovered stock before it explodes. However, chasing returns from big winners that have already made their moves may end up leaving the investor befuddled. Even though a stock has been hot, there is no guarantee that it will stay hot. Many investors may get stock tips from friends or colleagues. Of course the tips may be legitimate, but they could just be irrelevant. When it comes to stock picking strategies, investors might be best served to make sure that they have done the actual research themselves. Making trades based on tips or rumors may place the investor in a tough spot for future market success.
Following all the swirling information about publically traded companies can be quite a task. Every day there may be new pieces of news that emerge about a specific company. The prudent investor is typically able to keep abreast of the information, but most importantly figure out what news is worth paying attention to, and what news should be filtered out. Keeping a sharp eye on earnings reports and fundamental company data can play a big part in picking the right stocks for the portfolio. Once the numbers have been crunched, investors should be able to see things a little bit clearer and know what the general feel for the stock is. Of course there will be stocks that look good after thorough examination but still fail to perform as expected.
PROS AND CONS
Is institutional ownership a good thing or a bad thing? This is a matter of debate. In his best-selling book, “One Up on Wall Street”, Peter Lynch lists thirteen characteristics of “the perfect stock.” Regarding institutional ownership, he says: “Institutions don’t own it and the analysts don’t follow it”. He sees commodities that the big investment groups ignore as having the potential to be undervalued.
Investors who are able to wipe the slate clean and take a fresh look at a certain stock may be able to make more informed decisions that will hopefully lead to increased profits in the long-term. Figuring out when to sell an underperforming stock may end up being just as important as figuring out which stocks to buy. As the stock market continues to trade near record levels, investors will be closely following trading action heading into the latter half of the year. With many stocks reaching new highs, investors may need to make sure that they aren’t getting too overconfident with trades. When a few winning trades are strung together, investors may feel like they have the Midas touch and they can do no wrong. Nobody knows for sure how long stocks will stay in favor with investors. Keeping track of the portfolio’s contents can help when quick decisions need to be made. There may come a time when the tide turns and making a winning trade may seem impossible. Investors might want to have a plan in place in case of a sudden major market downturn. Keeping the portfolio stable during periods of market uncertainty may help prepare for unforeseen events in the future. Although there are many market enthusiasts that think the bull run may be on its last legs, there are just as many who believe that the best is yet to come, and there is much more room for stocks to climb.
There are various ways that the individual investor can approach stock picking. Starting from the top-down, investors may study overall market trends. This may include examining different sectors looking for the ones that are poised to prosper in the future. Once potential industries or sectors are identified, the investor can then start to sift through individual stocks within those groups. Investors starting from the bottom up may do just the opposite. They may choose to study individual companies that have been displaying strong performance, regardless of which sector they belong to.
CRISPR Therapeutics AG (:CRSP) stock stands 43.23% away from its 50-day simple moving average and also 59.35% away from the 200-day average.
Recently, the commodity stands -4.45% away from the 52-week high and 218.23% from the 52-week low. The RSI (Relative Strength Index), an indicator that shows price strength by comparing upward and downward close-to-close movements is 66.95 for CRISPR Therapeutics AG (:CRSP).
Amateur investors can sometimes become overwhelmed by the speed and volatility of the stock market. Often times, avoiding big mistakes early on can be the difference between staying in the game or being prematurely forced to the sidelines. One of the biggest mistakes that a new investor can make is not creating a realistic plan. A well-crafted plan will generally include risk tolerance, time horizon, and amount and frequency of investments. Having a clear plan for attaining goals can help the investor stay focused when the terrain gets rocky. Another common mistake for investors is buying high and selling low. Of course, everybody preaches the buy low sell high mantra, but it is much easier said than done. Getting caught up in the day to day market swings can lead the investor to do just the opposite and become a hot stock chaser instead of a disciplined decision maker.